Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy
Authors
Keywords
-
Journal
BMB Reports
Volume 47, Issue 12, Pages 697-702
Publisher
Korean Society for Biochemistry and Molecular Biology - BMB Reports
Online
2015-01-22
DOI
10.5483/bmbrep.2014.47.12.069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-κB activity
- (2013) Min Sha et al. Cancer Cell International
- Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development
- (2013) Mayur V. Jain et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling
- (2012) Ju-Hye Lee et al. APOPTOSIS
- Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
- (2012) Muthu K. Shanmugam et al. CANCER LETTERS
- STAT3 silencing enhances the efficacy of the HSV.tk suicide gene in gastrointestinal cancer therapy
- (2012) Ye-Hyeon Ahn et al. CLINICAL & EXPERIMENTAL METASTASIS
- Alterations in Cell Proliferation Related Gene Expressions in Gastric Cancer
- (2012) Kyungtae Kim et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Molecules of Natural Origin, Semi-synthesis and Synthesis with Anti-Inflammatory and Anticancer Utilities
- (2012) A. M. Lourenco et al. CURRENT PHARMACEUTICAL DESIGN
- Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression
- (2012) Yuan-Guo Wang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Current status of targeted therapies in advanced gastric cancer
- (2012) Ferdinando De Vita et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90
- (2012) Wen-Bo Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Acceleration of Gastric Tumorigenesis Through MKRN1-Mediated Posttranslational Regulation of p14ARF
- (2012) Aram Ko et al. JNCI-Journal of the National Cancer Institute
- Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways
- (2011) Radhamani Kannaiyan et al. APOPTOSIS
- Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers
- (2011) Srikumar M. Raja et al. CANCER BIOLOGY & THERAPY
- Molecularly targeted therapies in unresectable-metastatic gastric cancer. A systematic review
- (2011) Flora Zagouri et al. CANCER TREATMENT REVIEWS
- Quantitative Proteomics Reveals Cellular Targets of Celastrol
- (2011) Jakob Hansen et al. PLoS One
- Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
- (2010) Radhamani Kannaiyan et al. CANCER LETTERS
- Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway
- (2010) X. Pang et al. CANCER RESEARCH
- Multidisciplinary management of gastric cancer
- (2010) Yixing Jiang et al. CURRENT OPINION IN GASTROENTEROLOGY
- Celastrol Acts as a Potent Antimetastatic Agent Targeting 1 Integrin and Inhibiting Cell-Extracellular Matrix Adhesion, in Part via the p38 Mitogen-Activated Protein Kinase Pathway
- (2010) H. Zhu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents
- (2009) Teak-Chin Cheong et al. CANCER SCIENCE
- Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era
- (2009) Anna D Wagner et al. CURRENT OPINION IN ONCOLOGY
- Galectin-3 Increases Gastric Cancer Cell Motility by Up-regulating Fascin-1 Expression
- (2009) Seok–Jun Kim et al. GASTROENTEROLOGY
- Celastrol Synergistically Enhances Temozolomide Cytotoxicity in Melanoma Cells
- (2009) M. Chen et al. MOLECULAR CANCER RESEARCH
- The treatment of advanced gastric cancer: current strategies and future perspectives
- (2008) A. Cervantes et al. ANNALS OF ONCOLOGY
- Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression
- (2008) Yulun Huang et al. CANCER LETTERS
- A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
- (2008) T. Zhang et al. MOLECULAR CANCER THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started